Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Published:2005-05-28 Issue:4 Volume:7 Page:650-656
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

O'Meara Eileen¹,Lewis Eldrin²,Granger Chris³,Dunlap Mark E.⁴,McKelvie Robert S.⁵,Probstfield Jeffrey L.⁶,Young James B.⁷,Michelson Eric L.⁸,Ostergren Jan⁹,Carlsson Jonas¹⁰,Olofsson Bertil¹⁰,McMurray John¹,Yusuf Salim¹¹,Swedberg Karl¹²,Pfeffer Marc A.²

Affiliation:

1. Department of Cardiology; Western Infirmary; Glasgow Scotland G11 6NT United Kingdom

2. Brigham and Women's Hospital; Boston MA USA

3. Duke University Medical Center; Durham NC USA

4. Case Western Reserve University, Cleveland and VA Medical Center; OH USA

5. Hamilton General Hospital; Hamilton Ontario Canada

6. University of Washington; Seattle WA USA

7. Medicine, Cleveland Clinic Foundation; Cleveland USA

8. AstraZeneca LP; Wilmington DE USA

9. Karolinska Hospital; Stockholm SE Sweden

10. AstraZeneca, R and D Mölndal; Sweden

11. HGM-McMaster Clinic; Hamilton Ontario Canada

12. Department of Medicine; Sahlgrenska University Hospital/Östra; Göteborg Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Effect of candesartan on New York Heart Association functional class. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme;O'Meara;Eur Heart J,2004

2. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease;Bennett;Heart Lung,2002

3. Effects of controlled-release metoprolol in total mortality, hospitalizations, and well-being in patients with heart failure;Hjalmarson;JAMA,2000

4. Capturing the patient's view of change as a clinical outcome measure;Fischer;JAMA,1999

5. Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis;Strand;Rheumatology,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Physician Compliance with Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Study;Reviews in Cardiovascular Medicine;2023-09-18

2. Non‐adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography‐tandem mass spectrometry (results of a prospective multicentre study);European Journal of Heart Failure;2021-05-03

3. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire;European Journal of Heart Failure;2021-04

4. Epidemiology of heart failure with preserved ejection fraction;Nature Reviews Cardiology;2017-05-11

5. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial;Circulation: Heart Failure;2016-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3